Engineering Commons^™

A Strategy For Integrating Essential Three-Dimensional Microphysiological Systems Of Human Organs For Realistic Anticancer Drug Screening, Christopher Heylman, Agua Sobrino, Venktesh S. Shirure, Christopher Cw Hughes, Steven C. George

Biomedical Engineering

Cancer is one of the leading causes of morbidity and mortality around the world. Despite some success, traditional anticancer drugs developed to reduce tumor growth face important limitations primarily due to undesirable bone marrow and cardiovascular toxicity. Many drugs fail in clinical development after showing promise in preclinical trials, suggesting that the available in vitro and animal models are poor predictors of drug efficacy and toxicity in humans. Thus, novel models that more accurately mimic the biology of human organs are necessary for high-throughput drug screening. Three-dimensional (3D) microphysiological systems can utilize induced pluripotent stem cell technology, tissue engineering, and …

Slowing The Onset Of Hypoxia Increases Colony Forming Efficiency Of Connective Tissue Progenitor Cells In Vitro, Christopher M. Heylman, Tonya N. Caralla, Cynthia A. Boehm, Thomas E. Patterson, George F. Muschler

Biomedical Engineering

Background: Survival and colony formation by transplanted tissue derived connective tissue progenitor cells (CTPs) are thought to be important factors in the success of clinical tissue engineering strategies for bone regeneration. Transplantation of cells into defects larger than a few millimeters expose cells to a profoundly hypoxic environment. This study tested the hypothesis that delaying the onset of hypoxia will improve the survival and performance of CTPs in vitro.

Methods: To mimic declines seen in an avascular in vivo bone defect, colony forming efficiency by marrow derived nucleated cells was assessed under osteogenic conditions. Variation in the rate of …